FDA-cleared portable MRI imaging systems for point-of-care neurology
Hyperfine manufactures the Swoop system, an FDA-cleared ultra-low-field portable MRI device for brain imaging outside traditional radiology centers. The tech stack (Python, PyTorch, TensorFlow, AWS/GCP/Azure) reflects heavy investment in image processing and cloud infrastructure—critical for a hardware company shipping AI-augmented diagnostics. Current project focus on electromagnetic noise reduction, magnet characterization, and deep-learning model prototyping signals active R&D maturity. Hiring remains minimal (14 open roles, none posted in 30 days) despite ambitious scaling plans around manufacturing cost, yield improvement, and global regulatory expansion, suggesting near-term bottlenecks in operations rather than headcount.
Hyperfine is a public medical device manufacturer (Nasdaq: HYPR, founded 2014) headquartered in Guilford, Connecticut. The company's core product, the Swoop system, received FDA clearance in 2020 and represents the first portable, ultra-low-field MRI capable of brain imaging at bedside, urgent care, or field settings. The system targets neuroradiology and neurocritical care applications where traditional MRI access is impractical. Engineering and product teams are actively working on electromagnetic system improvements, design-for-manufacturability optimization, and a broader intelligent medical product suite. Current operational challenges center on manufacturing scalability—cost reduction, yield management, and production efficiency—alongside regulatory navigation for global market entry.
Python, PyTorch, and TensorFlow for image processing and AI models; AWS, GCP, and Azure for cloud infrastructure; Docker and PostgreSQL for backend systems. Node.js and Flask support application services.
Hyperfine is headquartered in Guilford, Connecticut and operates as a public company (Nasdaq: HYPR) with 51–200 employees. All current hiring is focused in the United States.
Other companies in the same industry, closest in size